BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20448536)

  • 1. WITHDRAWN: Effect of obesity at the pathologic response to neoadjuvant chemotherapy among premenopausal Tunisian women with breast cancer.
    Kacem M; Awatef M; Amel L; Jihen M; Slim BA
    Obesity (Silver Spring); 2010 May; ():. PubMed ID: 20448536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer.
    Litton JK; Gonzalez-Angulo AM; Warneke CL; Buzdar AU; Kau SW; Bondy M; Mahabir S; Hortobagyi GN; Brewster AM
    J Clin Oncol; 2008 Sep; 26(25):4072-7. PubMed ID: 18757321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of obesity on diagnosis and treatment of breast cancer.
    Deglise C; Bouchardy C; Burri M; Usel M; Neyroud-Caspar I; Vlastos G; Chappuis PO; Ceschi M; Ess S; Castiglione M; Rapiti E; Verkooijen HM
    Breast Cancer Res Treat; 2010 Feb; 120(1):185-93. PubMed ID: 19597985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of body mass index in locally advanced breast cancer.
    Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Islam R; Hortobagyi GN; Cristofanilli M
    Clin Cancer Res; 2008 Mar; 14(6):1718-25. PubMed ID: 18347172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Weighing in' on screening mammography.
    Berz D; Sikov W; Colvin G; Weitzen S
    Breast Cancer Res Treat; 2009 Apr; 114(3):569-74. PubMed ID: 18491226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
    Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
    Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of body mass index on clinical outcomes in triple-negative breast cancer.
    Ademuyiwa FO; Groman A; O'Connor T; Ambrosone C; Watroba N; Edge SB
    Cancer; 2011 Sep; 117(18):4132-40. PubMed ID: 21387276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with being underweight, overweight and obese among ever-married non-pregnant urban women in Bangladesh.
    Khan MM; Kraemer A
    Singapore Med J; 2009 Aug; 50(8):804-13. PubMed ID: 19710981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
    Wang H; Yee D; Potter D; Jewett P; Yau C; Beckwith H; Watson A; O'Grady N; Wilson A; Brain S; Pohlmann P; ; Blaes A
    Breast Cancer Res Treat; 2024 Apr; 204(3):589-597. PubMed ID: 38216819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in prepregnancy body mass index between the first and second pregnancies and risk of large-for-gestational-age birth.
    Getahun D; Ananth CV; Peltier MR; Salihu HM; Scorza WE
    Am J Obstet Gynecol; 2007 Jun; 196(6):530.e1-8. PubMed ID: 17547882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors.
    Skírnisdóttir I; Sorbe B
    Acta Obstet Gynecol Scand; 2010; 89(1):101-7. PubMed ID: 19878086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
    Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
    J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
    Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
    Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The obesity paradox: body mass index and outcomes in patients with heart failure.
    Curtis JP; Selter JG; Wang Y; Rathore SS; Jovin IS; Jadbabaie F; Kosiborod M; Portnay EL; Sokol SI; Bader F; Krumholz HM
    Arch Intern Med; 2005 Jan; 165(1):55-61. PubMed ID: 15642875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial.
    Wang H; Yee D; Potter D; Jewett P; Yau C; Beckwith H; Watson A; O'Grady N; Wilson A; Brain S; Pohlmann P; Blaes A
    Res Sq; 2023 May; ():. PubMed ID: 37397981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and prostate cancer clinical risk factors at presentation: data from CaPSURE.
    Kane CJ; Bassett WW; Sadetsky N; Silva S; Wallace K; Pasta DJ; Cooperberg MR; Chan JM; Carroll PR
    J Urol; 2005 Mar; 173(3):732-6. PubMed ID: 15711258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer.
    Palma D; Pickles T; Tyldesley S;
    BJU Int; 2007 Aug; 100(2):315-9. PubMed ID: 17617138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity on survival in epithelial ovarian cancer.
    Pavelka JC; Brown RS; Karlan BY; Cass I; Leuchter RS; Lagasse LD; Li AJ
    Cancer; 2006 Oct; 107(7):1520-4. PubMed ID: 16941453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic, psychosocial, behavioural, and psychological determinants of BMI among young women: differing patterns for underweight and overweight/obesity.
    Ali SM; Lindström M
    Eur J Public Health; 2006 Jun; 16(3):325-31. PubMed ID: 16162598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.